RYR2 and catecholaminergic polymorphic ventricular tachycardia: Sixty to sixty-five percent of CPVT patients carry a pathogenic variant in the RYR2 gene (encoding the ryanodine receptor 2), which is transmitted in an autosomal dominant pattern.